SHP2 promotes the expression of proangiogenic factor SOX7 through c-JUN signaling to promote pathological angiogenesis in tumors, while a decreased tumor angiogenesis was observed in mice with SHP2-knockdown endothelial cells [82]. Here, PTPN11 is linked to neoplasm.